Finance
Markets
No recent trading data. The last price we hold for COO is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

COO

stock Healthcare Medical Instruments & Supplies
Cooper Companies (The)
$60.34 +0.85 (+1.43%) Delayed · quoted 46d ago
Concerning 37% Slipping

What the indicators say

Bearish 0 of 5 trend signals bullish
Momentum · RSI 14 Leaning bearish
40
0oversold 30overbought 70100

RSI 40 — soft momentum, not yet oversold.

EMA 21 $61.58
Below
Near-term trend is down
SMA 50 $65.16
Below
Medium-term trend is down
SMA 200 $72.93
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $64.21
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $59.59 High $60.58
Open
$60.34
+1.43%
Close
$60.34
+1.43%
52-week range where the price sits across its year
52w low $58.89 52w high $89.83
Current
$60.34
Prev close
$59.49
Volume 1.61× the 3-month average
0 avg 2× avg
Today
3.76M
3-mo avg
2.34M

Earningscalendar synced from Yahoo 57d ago

Most recent
Mar 5138 days ago
Next expected
Jun 447 days ago

Recent earnings dates

  • Mar 5 138 days ago
  • Dec 4, 2025 229 days ago
  • Aug 27, 2025 328 days ago
  • May 29, 2025 418 days ago

Past earnings dates come from COO’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Jan 2026 earnings, against the latest price), COO’s fundamentals read as fair overall.

Latest SEC earnings are from Jan 2026; the price-based ratios may lag a more recent quarter.

P/E ratio Fair
30.0x

At 30.0x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
9.2%

A 9.2% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Weak
4.6%

A 4.6% return on equity is weak; owners' capital is barely being put to work.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
3.0%

A 3.0% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Strong
0.50

At 0.50, the company carries less in liabilities than in equity, a conservative balance sheet.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.89

At 1.89, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+5.1%

Revenue grew 5.1% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-4.4%

Net income fell 4.4% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $2.9B$3.3B$3.6B$3.9B$4.1B
Net income $2.9B$385.8M$294.2M$392.3M$374.9M
Diluted EPS $59.16$1.94$1.48$1.96$1.87
Dividend / share $0.03$0.01$0.01——
Total assets $9.6B$11.5B$11.7B$12.3B$12.4B
Total liabilities $2.7B$4.3B$4.1B$4.2B$4.2B
Shareholder equity $6.9B$7.2B$7.6B$8.1B$8.2B

Leadershipsynced from SEC 57d ago

  • White Albert G Iii President & CEO · Director
  • Andrews Brian G EVP, CFO & Treasurer
  • Mcbride Daniel G EVP & Chief Operating Officer
  • Warner Gerard H Iii President, CooperVision, Inc.
  • Sheffield Holly R President, CSI
  • Carbone Barbara Director
  • Jay Colleen Director
  • Kurzius Lawrence Erik Director
  • Lucchese Cynthia L Director
  • Madden Teresa S Director
  • Rivas Maria Director
  • Rosebrough Walter M Jr Director
  • Weiss Robert S Director

Officers and board are drawn from COO’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays twice a year
2025 total
—
2026 so far
$0.00000 payments

Projection scales COO’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Jul 26, 2023 $0.0075
  • Jan 20, 2023 $0.0075
  • Jul 26, 2022 $0.0075
  • Jan 20, 2022 $0.0075
  • Jul 26, 2021 $0.0075

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved